Laura C.
- Country
- Italy
- Department
- Oncology
Research Overview
- Dexamethasone Premedication to Prevent Grade ≥2 Interstitial Lung Disease in Breast Cancer Patients Receiving Trastuzumab Deruxtecan
- Phase III Randomized Study of Saruparib and Camizestrant Versus CDK4/6 Inhibitor and Endocrine Therapy in BRCA1/2 or PALB2 Mutated HR+/HER2- Advanced Breast Cancer
- Phase 2 Evaluation of Olaparib and Pembrolizumab in HRRm and HRD-Positive Advanced Cancer
Data & Insights
Has run more than one trial at 21 of 122 partner sites.
Specializations
Breast Cancer Specialization
The investigator focuses on advanced therapeutic approaches for various types of breast cancer, with particular emphasis on hormone receptor-positive (ER+) and HER2-negative variants. Their research encompasses both early-stage and metastatic disease management.
- Triple-negative breast cancer treatment
- BRCA-related metastatic breast cancer
- Early-stage breast cancer therapy
Special attention is given to endocrine-based therapeutic strategies and innovative combination treatments.
Precision Oncology
The investigator specializes in targeted therapies for specific genetic mutations and molecular markers. Their work includes research on PALB2-related cancers and HRR-mutated tumors.
- Genetic mutation-specific treatments
- Molecular targeting approaches
- Biomarker-driven therapy selection
Research includes evaluation of novel therapeutic combinations for genetically defined cancer subtypes.
Innovative Therapeutic Approaches
The investigator explores cutting-edge treatment combinations including immunotherapy and targeted molecular agents. Their work encompasses both adjuvant and advanced disease settings.
- Combination immunotherapy strategies
- Novel therapeutic compounds
- Advanced cancer treatment protocols
Focus areas include treatment optimization for resistant and advanced-stage cancers.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.